Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures Growth (1y) (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures Growth (1y) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 227.76% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 204.00% |
| Dec 31, 2020 | -104.03% |
| Sep 30, 2020 | -95.24% |
| Jun 30, 2020 | -91.37% |
| Mar 31, 2020 | 567.45% |
| Dec 31, 2019 | 1,511.01% |
| Sep 30, 2019 | 1,975.09% |
| Jun 30, 2019 | 115.18% |
| Mar 31, 2019 | -94.53% |
| Dec 31, 2018 | -115.78% |
| Sep 30, 2018 | 26.67% |
| Jun 30, 2018 | -3,061.65% |
| Mar 31, 2018 | 3,063.92% |
| Dec 31, 2017 | 360.28% |
| Sep 30, 2017 | -34.97% |
| Jun 30, 2017 | -44.00% |
| Mar 31, 2017 | -64.40% |
| Dec 31, 2016 | -339.68% |
| Sep 30, 2016 | 1,351.25% |
| Jun 30, 2016 | 413.49% |